Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 106069
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106069
Table 3 Comparison of postoperative characteristics between the two groups, n (%)

Experimental group (n = 44)
Control group (n = 46)
P value
Postoperative CRP [M, (Q1, Q3), mg/L]17.98 (7.3, 34.2)30.8 (16.1, 47.1)0.066
Postoperative white blood cell count [M, (Q1, Q3), 109/L]8.9 (7.9, 11.2)10.6 (9.0, 13.0)0.069
Postoperative neutrophil percentage [M, (Q1, Q3), %]81.7 (75.7, 84.9)82.4 (76.7, 84.7)0.577
Postoperative maximum body temperature [M, (Q1, Q3), °C]36.8 (36.7, 36.9)36.8 (36.8, 37.5)0.149
NRS 1 day postoperative [M, (Q1, Q3), points]3 (2, 3.6)4 (3, 5)< 0.001
NRS 4 days postoperative [M, (Q1, Q3), points]1 (1, 2.0)2 (1, 2.3)< 0.001
Delayed postoperative bleeding> 0.999
    Yes0 (0)0 (0)
    No44 (100)46 (100)
Delayed postoperative perforation> 0.999
    Yes0 (0)0 (0)
    No44 (100)46 (100)
Postoperative infection0.008
    Yes7 (15.91)19 (41.30)
    No37 (84.09)27 (58.70)
The days of use antibiotic [M, (Q1, Q3), day]3.5 (1.3, 5)5 (3.8, 6)0.013
Postoperative hospital stays [M, (Q1, Q3), day]6 (5, 7)6 (5, 7)0.314
Total hospitalization costs [M, (Q1, Q3), CNY]19843.3 (18361.6, 22260.5)20862.5 (19475.0, 24398.3)0.075